Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Weighted Average) (2016 - 2025)

Abeona Therapeutics has reported Shares Outstanding (Weighted Average) over the past 15 years, most recently at $53.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $53.0 million for Q4 2025, up 29.0% from a year ago — trailing twelve months through Dec 2025 was $53.0 million (up 29.0% YoY), and the annual figure for FY2025 was $53.0 million, up 29.0%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $53.0 million at Abeona Therapeutics, up from $52.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ABEO hit a ceiling of $94.2 million in Q1 2021 and a floor of $589681.0 in Q3 2024.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $7.7 million (2022), compared with a mean of $21.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 97.62% in 2024 and later skyrocketed 8751.95% in 2025.
  • Abeona Therapeutics' Shares Outstanding (Weighted Average) stood at $3.9 million in 2021, then soared by 99.65% to $7.9 million in 2022, then dropped by 3.2% to $7.6 million in 2023, then soared by 439.41% to $41.0 million in 2024, then increased by 29.0% to $53.0 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $53.0 million (Q4 2025), $52.2 million (Q3 2025), and $51.2 million (Q2 2025) per Business Quant data.